Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia.
about
Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosisMesenchymal stem/stromal cells as a delivery platform in cell and gene therapiesStem cell therapy to cure type 1 diabetes: from hype to hope.Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes MellitusMesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal modelsThe immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation.Update on islet cell transplantation for type 1 diabetesCurrent status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation.Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway.The antidiabetic effect of MSCs is not impaired by insulin prophylaxis and is not improved by a second dose of cells.Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines.Efficacy and safety of autologous bone marrow derived hematopoietic stem cell transplantation in patients with type 2 DM: A 15 months follow-up studyCongenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes.Stem cell transplantation improves aging-related diseasesStem cell-based strategies for the treatment of type 1 diabetes mellitusProtection of rat pancreatic islet function and viability by coculture with rat bone marrow-derived mesenchymal stem cells.Adipose tissue-derived mesenchymal stem cells exert in vitro immunomodulatory and beta cell protective functions in streptozotocin-induced diabetic mice model.Metabolic and pancreatic effects of bone marrow mesenchymal stem cells transplantation in mice fed high-fat diet.Mesenchymal stem cell effects on T-cell effector pathways.Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice.Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicineComparison of adipose tissue- and bone marrow- derived mesenchymal stem cells for alleviating doxorubicin-induced cardiac dysfunction in diabetic rats.Regulation of Immunity via Multipotent Mesenchymal Stromal Cells.Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes.A Method for Performing Islet Transplantation Using Tissue-Engineered Sheets of Islets and Mesenchymal Stem CellsInterplay between mesenchymal stem cells and lymphocytes: implications for immunotherapy and tissue regeneration.Enhanced function of pancreatic islets co-encapsulated with ECM proteins and mesenchymal stromal cells in a silk hydrogel.Transcriptional profiling reveals intrinsic mRNA alterations in multipotent mesenchymal stromal cells isolated from bone marrow of newly-diagnosed type 1 diabetes patientsThird-party mesenchymal stem cells improved human islet transplantation in a humanized diabetic mouse modelA new scaffold containing small intestinal submucosa and mesenchymal stem cells improves pancreatic islet function and survival in vitro and in vivo.Synergistic suppression of autoimmune arthritis through concurrent treatment with tolerogenic DC and MSC.Umbilical cord-derived mesenchymal stem cells reversed the suppressive deficiency of T regulatory cells from peripheral blood of patients with multiple sclerosis in a co-culture - a preliminary study.CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success?Bone marrow and pancreatic islets: an old story with new perspectives.Mesenchymal stromal cells for cell therapy: besides supporting hematopoiesis.Mesenchymal stromal cells for tissue-engineered tissue and organ replacements.Harnessing the immunomodulatory and tissue repair properties of mesenchymal stem cells to restore β cell function.Immunomodulatory properties of dental tissue-derived mesenchymal stem cells.Bone marrow stem cell as a potential treatment for diabetes.Mesenchymal stromal cells to halt the progression of type 1 diabetes?
P2860
Q21245469-AF236779-1353-4B86-A27D-37224DFAEB05Q26799107-04B73EFA-7A0B-40B5-96DD-44911CE194CFQ26823294-3902EB91-25AD-46A1-BF37-1F468D6340EAQ26864580-C0DF6BF9-2A39-4449-8271-C0E385DBF0FAQ28085080-439E2718-0E38-4BF3-BAD1-92AA12C227A9Q30409961-FCF25C1C-998E-4286-B373-FA0F663E2579Q30419163-5179CD01-C73F-4BB8-885F-EAD7E05114F6Q30430008-299D7684-367A-46CA-9488-B38DD7B31D0FQ31101562-E4D91D54-076D-47E8-A777-10C11FDFED5DQ33815233-BF9E4459-0164-4EB8-9921-12C8D3B3E3A7Q34292905-2CAF38D7-4107-4FA8-A5FE-D2EC9FEFF53AQ34319707-A1D496E8-240A-4F3B-B11F-FAFD5E10A962Q34355278-FFBD3C1C-1FE6-4CA1-B399-10ACC99FB3D8Q34391056-6C5DC3D3-3883-4EFF-A61E-C09DE066C68AQ34417324-24906088-84CD-454A-9C1C-AF7B674BEA54Q34545317-BD0747A7-5632-4CE4-A1E9-19EA2AE69806Q35373250-AF1AE167-E755-44DF-A922-160258D699F3Q35552255-E78029EF-B858-4209-9B7D-C0400A56BB57Q35558505-DFD563C9-CD50-493B-AF89-D04E064B39BBQ35609423-F28FC0EB-A38B-4894-A5BB-B050570769CAQ35889077-F6169CE6-7BB4-47D2-AFB2-F24E81DF0031Q35987027-0286CC28-8ED8-47E0-A019-8FF6860BF23AQ36025982-04446162-D600-450F-BC2B-6BB03C1D19DFQ36249780-B314A597-DD70-4499-9512-1D79A0225BA0Q36330032-D65CD936-0705-4C58-8BFC-D5127F70CC41Q36375063-F658B434-81EA-4D4E-83BA-049E00005CE0Q36981232-F537CFD4-8A1D-425F-B652-421E71FF3462Q37089931-47F72A2C-2540-4134-B747-B9CD3B0C5C1FQ37181396-8B5F35B9-C815-44A9-84F0-F7FB07B23270Q37527822-189CA31F-9430-4BBD-82EB-579B6562825DQ37661080-47F94EA9-A766-4321-9AE7-CD228E57965EQ37687257-9AA83C4A-C89D-438E-9F8D-7F0ABD902632Q37692502-C7BD4160-FA33-4E96-93F0-280F7E63C0FFQ37780807-A4CCF13C-AD90-4173-92BB-1278078C96A3Q37970019-CAE42AC6-0864-4F34-A800-F40B2EC94F48Q37976114-3D04C9B1-F89C-4322-A42C-7A8BEAD5AD1FQ38032498-101E8F1F-B3A8-45F8-93B9-BC396F4AF40CQ38086839-BE160458-5621-4428-A095-E79B7C754649Q38106720-D3AA5477-0874-4FEF-8634-6708A2216C86Q38499617-48B7B5D8-AD6A-416E-B8FD-FC5C12B7064D
P2860
Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Autologous bone marrow-derived ...... nduce sustained normoglycemia.
@en
Autologous bone marrow-derived ...... nduce sustained normoglycemia.
@nl
type
label
Autologous bone marrow-derived ...... nduce sustained normoglycemia.
@en
Autologous bone marrow-derived ...... nduce sustained normoglycemia.
@nl
prefLabel
Autologous bone marrow-derived ...... nduce sustained normoglycemia.
@en
Autologous bone marrow-derived ...... nduce sustained normoglycemia.
@nl
P2093
P1476
Autologous bone marrow-derived ...... nduce sustained normoglycemia.
@en
P2093
Adolfo Garcia-Ocana
Imene Boumaza
Maryam Feili-Hariri
Suganya Srinivasan
William T Witt
P356
10.1016/J.JAUT.2008.10.004
P577
2008-12-04T00:00:00Z